Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/2003
09/16/2003US6620802 Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist
09/16/2003US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or
09/16/2003US6620779 Administering to an individual for tumor treatment a chemotherapeutically effective amount of antitumor agent carboplatin, and erythropoietin a hematocrit elevator which is administered befor or concurrently with antitumor agent
09/16/2003US6620778 Cysteine/glycine rich peptides
09/16/2003US6620594 Uncoupling protein homologue: UCP 3
09/16/2003US6620419 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution)
09/16/2003US6620415 Parkinson's disease treatment
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2238875C Tri-aryl ethane derivatives as pde iv inhibitors
09/16/2003CA2235421C Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2231025C Novel compounds of 2-aminoindane, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2215695C .beta.-sheet mimetics and use thereof as protease inhibitors
09/16/2003CA2172493C Use of angiotensin iii and analogs thereof in tissue repair
09/16/2003CA2167408C Process for making hiv protease inhibitors
09/16/2003CA2105683C N-¬¬4,5-dihydroxy-and 4,5,8-trihydroxy-9,10-dihydro-9, 10-dioxo-2-anthracene-yl|carbonyl|amino acids useful in the therapy of osteoarticular affections
09/16/2003CA2102782C 2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
09/16/2003CA2099898C Antibacterial antiplaque oral composition
09/16/2003CA2081343C Therapeutic agents for the treatment of multidrug resistance to cancers
09/16/2003CA2078759C Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
09/16/2003CA2047857C (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
09/12/2003WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003WO2003074684A1 Cells capable of differentiating into myocardium-like cells
09/12/2003WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003WO2003074564A1 Novel hemepeptide
09/12/2003WO2003074532A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
09/12/2003WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003WO2003074529A2 iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
09/12/2003WO2003074525A1 Nitrogen-containing heterocyclic compound
09/12/2003WO2003074520A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
09/12/2003WO2003074517A1 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity
09/12/2003WO2003074516A1 Phthalimide carboxylic acid derivatives
09/12/2003WO2003074515A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003WO2003074513A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
09/12/2003WO2003074512A1 Isoquinoline derivatives
09/12/2003WO2003074504A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
09/12/2003WO2003074485A2 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074479A1 Semicarbazide derivatives and their use as antithrombotics
09/12/2003WO2003074469A1 Novel cinnamate salts, method for production and use thereof as medicaments
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/12/2003WO2003074082A1 Formulations and methods of using nitric oxide mimetics in cancer treatment
09/12/2003WO2003074072A1 Methods and compositions for the treatment of ischemia
09/12/2003WO2003074065A1 Identification of free-b-ring flavonoids as potent cox-2 inhibitors
09/12/2003WO2003074062A2 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
09/12/2003WO2003074055A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
09/12/2003WO2003074050A1 Thiazole and oxazole derivatives which modulate ppar activity
09/12/2003WO2003074049A1 Antitumor agents
09/12/2003WO2003074045A1 Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with angiogenesis inhibitor
09/12/2003WO2003074043A1 Body temperature elevating agents
09/12/2003WO2003074042A1 Uncoupling protein expression promoter
09/12/2003WO2003074038A1 Methods for treating diseases related to intraocular pressure
09/12/2003WO2003074037A1 Treatment of female sexual dysfunction
09/12/2003WO2003074034A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
09/12/2003WO2003074025A2 Pressurised metered dose inhalers containing solutions of beta-2 agonists
09/12/2003WO2003073990A2 Treatment for asthma or allergies
09/12/2003WO2003073987A2 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073841A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
09/12/2003WO2003053960A3 Quinline derivates and their use as mek inhibitors
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003045940A3 Benzazepine derivatives and their use as 5-ht ligands
09/12/2003WO2003045272A3 ORAL IMMUNOSTIMULATION OF MAMMALS, BIRDS, FISH AND REPTILES FROM (1-4) LINKED ß-D-MANNURONIC ACID
09/12/2003WO2003041757A3 Catheter injectable depot compositions and uses thereof
09/12/2003WO2003039596B1 Photodynamic therapy for the treatment of hair loss
09/12/2003WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity
09/12/2003WO2003035884A3 Transient immortalization
09/12/2003WO2003034995A3 Integrin targeting compounds
09/12/2003WO2003034987A3 Androgen receptor modulators and methods of use thereof
09/12/2003WO2003006612A3 Production of transduced hematopoietic progenitor cells
09/12/2003WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002060871A3 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002018572A3 Membrane penetrating peptides and uses thereof
09/12/2003WO2002004443A3 Heterocycle carboxamides as antiviral agents
09/12/2003WO2001095785A3 Modulation of immune response and methods based thereon
09/12/2003CA2481307A1 Phthalimide carboxylic acid derivatives
09/12/2003CA2478618A1 Isoquinoline derivatives
09/12/2003CA2478612A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
09/12/2003CA2478528A1 Semicarbazide derivatives and the use thereof as antithrombotics
09/12/2003CA2478520A1 Thiazole and oxazole derivatives which modulate ppar activity
09/12/2003CA2478425A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
09/12/2003CA2478145A1 Formulations and methods of using nitric oxide mimetics in cancer treatment
09/12/2003CA2478050A1 Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents
09/12/2003CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003CA2477785A1 Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
09/12/2003CA2477721A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477667A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
09/12/2003CA2477505A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477406A1 Dna vaccine against proliferating endothelial cells and methods of use thereof
09/12/2003CA2477400A1 Treatment for asthma or allergies
09/12/2003CA2477392A1 Methods for treating diseases related to intraocular pressure
09/12/2003CA2477387A1 Treatment of female sexual dysfunction
1 ... 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 ... 1564